The Israeli Ministry of Economy signed a Free Export Order for medical cannabis last month. The order allows for the implementation of an earlier decision for medical cannabis that…
IPOT.C
Isracann Biosciences (IPOT.C) is accelerating efforts to service an anticipated increase in demand for both domestic and EU markets. Isracanna is Israel’s only pure pot play—situated in one of…
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next…
There’s a lot going on underneath the surface with Isracann Biosciences (IPOT.C). A year in review won’t be much, mostly because this company hasn’t been public for a year….
On December 17, 2019 Isracann (IPOT.C) announced that it has entered into an Memorandum of Understanding (MOU) for a joint venture (JV) with an additional cannabis farm property in…
Isracann Biosciences (IPOT.C) got the regulatory nod from the Israeli Land Authority for their land use and facility design, but before they can get started with construction of their…
Isracann Biosciences (IPOT.C), an Israel-based cannabis play, has engaged the services of LinC by Growing Smart to draw a project roadmap for their proposed 230,000 square foot production facility….
Being “original” in business is a double-edged sword. Yes – it’s good to stand out in the crowd. But – when you’re all alone – investors may fret that…
As a general rule, I’m against any company with ‘cann’ or ‘canna’ in its title. You could make a drinking game out of reading the names of cannabis companies…